CAS 13653-84-4
:1,4-Di(4-carboxyphenyl)benzene
[1,1':4',1''-Terphenyl]-4,4''-dicarboxylic Acid
CAS:Formula:C20H14O4Purity:95%Color and Shape:SolidMolecular weight:318.3228[1,1':4',1''-Terphenyl]-4,4''-dicarboxylic acid
CAS:[1,1':4',1''-Terphenyl]-4,4''-dicarboxylic acidPurity:98%Molecular weight:318.33g/mol[p-Terphenyl]-4,4''-dicarboxylic Acid
CAS:Controlled ProductApplications Used in the synthesis of substituted terphenyls.
References Strukelj, M., et al.: Science, 267, 1969 (1995), Burroughes, J., et al.: Nature, 347, 589 (1990),Formula:C20H14O4Color and Shape:NeatMolecular weight:318.32[1,1′:4′,1”-Terphenyl]-4,4”-dicarboxylic Acid
CAS:Formula:C20H14O4Purity:95%Color and Shape:Liquid, No data available.Molecular weight:318.328[p-Terphenyl]-4,4''-dicarboxylic acid
CAS:4,4’-Dicarboxy-p-terphenyl is a disulfide amide with the molecular formula C14H10N2O2S. It is a chemical compound that has been shown to have antimicrobial activity. The antibacterial activity of 4,4’-Dicarboxy-p-terphenyl was evaluated by preparing a series of in vitro assays. The results showed that 4,4’-Dicarboxy-p-terphenyl inhibited the growth of bacteria and fungi at concentrations above 10 μg/mL. This drug also has been demonstrated to be effective against trifluoroacetic acid (TFA) induced congestive heart failure in experimental models. 4,4’-Dicarboxy-p-terphenyl has been found to have therapeutic potential for the treatment of metabolic disorders such as diabetes and hypertension. Structural analysis revealed that this drug contains a redox
Formula:C20H14O4Purity:Min. 95%Molecular weight:318.32 g/mol




